Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10:351–65.
Di Bonito P, Pacifico L, Licenziati MR, Maffeis C, Morandi A, Manco M, et al. Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. Nutr Metab Cardiovasc Dis. 2020;30:1840–7.
Marzuillo P, Grandone A, Di Sessa A, Guarino S, Diplomatico M, Umano GR, et al. Anthropometric and Biochemical Determinants of Estimated Glomerular Filtration Rate in a Large Cohort of Obese Children. J Ren Nutr. 2018;28:359–62.
Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864–73.
Di Sessa A, Guarino S, Umano GR, Arenella M, Alfiero S, Quaranta G, et al. MAFLD in Obese Children: A Challenging Definition. Children (Basel). 2021;8:247.
Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol. 2020;19:359–66.
Genovesi S, Antolini L, Orlando A, Gilardini L, Bertoli S, Giussani M, et al. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children. Front Endocrinol (Lausanne). 2020;11:27.
Damanhoury S, Newton AS, Rashid M, Hartling L, Byrne JLS, Ball GDC. Defining metabolically healthy obesity in children: a scoping review. Obes Rev. 2018;19:1476–91.
Di Bonito P, Miraglia Del Giudice E, Chiesa C, Licenziati MR, Manco M, Franco F, et al. Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype. Nutr Metab Cardiovasc Dis. 2018;28:1230–6.
Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23:956–66.
Rhee CM, Ahmadi SF, Kalantar-Zadeh K. The dual roles of obesity in chronic kidney disease: a review of the current literature. Curr Opin Nephrol Hypertens. 2016;25:208–16.
Panwar B, Hanks LJ, Tanner RM, Muntner P, Kramer H, McClellan WM, et al. Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int. 2015;87:1216–22.
Savino A, Pelliccia P, Chiarelli F, Mohn A. Obesity-related renal injury in childhood. Horm Res Paediatr. 2010;73:303–11.
Di Bonito P, Di Sessa A. New Diagnostic Criteria for Hypertension in Children and Adolescents: Lights and Shadows. Children (Basel). 2020;7:196.
Martinez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernandez-Garcia JC. Obesity-related glomerulopathy: Current approaches and future perspectives. Obes Rev. 2022;23:e13450.
Castro BBA, Foresto-Neto O, Saraiva-Camara NO, Sanders-Pinheiro H. Renal lipotoxicity: Insights from experimental models. Clin Exp Pharmacol Physiol. 2021;48:1579–88.
Colasante AM, Bartiromo M, Nardolillo M, Guarino S, Marzuillo P, Mangoni di SSG, et al. Tangled relationship between insulin resistance and microalbuminuria in children with obesity. World J Clin Pediatr. 2022;11:455–62.
Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol. 2011;119:e6–10.
Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease’. Kidney Int. 2013;84:622–3.
Kovesdy CP, Furth SL, Zoccali C. World Kidney Day Steering C. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Can J Kidney Health Dis. 2017;4:2054358117698669.
Kotsis V, Martinez F, Trakatelli C, Redon J. Impact of Obesity in Kidney Diseases. Nutrients. 2021;13:4482.
Nawaz S, Chinnadurai R, Al-Chalabi S, Evans P, Kalra PA, Syed AA, et al. Obesity and chronic kidney disease: A current review. Obes Sci Pract. 2023;9:61–74.
Sanad M, Gharib A. Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome. Pediatr Nephrol. 2011;26:2193–9.
Di Sessa A, Umano GR, Cirillo G, Passaro AP, Verde V, Cozzolino D, et al. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant. World J Gastroenterol. 2020;26:5474–83.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140:e20171904.
Gicchino MF, Di Sessa A, Guarino S, Miraglia Del Giudice E, Olivieri AN, Marzuillo P. Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis. Eur J Pediatr. 2021;180:655–61.
Marzuillo P, Di Sessa A, Cirillo G, Umano GR, Pedulla M, La Manna A, et al. Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity. Pediatr Res. 2020;88:300–4.
Marzuillo P, Guarino S, Di Sessa A, Rambaldi PF, Reginelli A, Vacca G, et al. Congenital Solitary Kidney from Birth to Adulthood. J Urol. 2021;205:1466–75.
Cho MH. Measurement of urinary protein in children. Child Kidney Dis. 2022;26:69–73.
Correia-Costa L, Schaefer F, Afonso AC, Bustorff M, Guimaraes JT, Guerra A, et al. Normalization of glomerular filtration rate in obese children. Pediatr Nephrol. 2016;31:1321–8.
Mackowiak-Lewandowicz K, Ostalska-Nowicka D, Zaorska K, Kaczmarek E, Zachwieja J, Witt M, et al. Chronic kidney disease predictors in obese adolescents. Pediatr Nephrol. 2022;37:2479–88.
Cheng CH. Albuminuria in childhood is a risk factor for chronic kidney disease and end-stage renal disease. Pediatr Neonatol. 2016;57:263–4.
Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens. 2008;17:450–6.
Correia-Costa L, Azevedo A, Caldas, Afonso A. Childhood Obesity and Impact on the Kidney. Nephron. 2019;143:8–11.
Garcia-Carro C, Vergara A, Bermejo S, Azancot MA, Sellares J, Soler MJ. A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management. Front Med (Lausanne). 2021;8:655871.
De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant. 2013;28:29–36.
Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311:F1087–F108.
Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, et al. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis. 2015;66:984–92.
Tsai WC, Wu HY, Peng YS, Ko MJ, Wu MS, Hung KY, et al. Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis. Medicine (Baltimore). 2016;95:e3013.
La Scola C, Guarino S, Pasini A, Capalbo D, Liguori L, Di Sessa A, et al. Effect of Body Mass Index on Estimated Glomerular Filtration Rate Levels in Children With Congenital Solitary Kidney: A Cross-Sectional Multicenter Study. J Ren Nutr. 2020;30:261–7.
Joo HJ, Kim GR, Choi DW, Joo JH, Park EC. Uric acid level and kidney function: a cross-sectional study of the Korean national health and nutrition examination survey (2016-2017). Sci Rep. 2020;10:21672.
Souweine JS, Corbel A, Rigothier C, Roque CD, Hadjadj S, Cristol JP, et al. Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular risk. Ann Biol Clin (Paris). 2019;77:26–35.
Tsioufis C, Mazaraki A, Dimitriadis K, Stefanidis CJ, Stefanadis C. Microalbuminuria in the paediatric age: current knowledge and emerging questions. Acta Paediatr. 2011;100:1180–4.
Calcaterra V, Larizza D, De Silvestri A, Albertini R, Vinci F, Regalbuto C, et al. Gender-based differences in the clustering of metabolic syndrome factors in children and adolescents. J Pediatr Endocrinol Metab. 2020;33:279–88.
Barstad LH, Juliusson PB, Johnson LK, Hertel JK, Lekhal S, Hjelmesaeth J. Gender-related differences in cardiometabolic risk factors and lifestyle behaviors in treatment-seeking adolescents with severe obesity. BMC Pediatr. 2018;18:61.
Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25:1657–66.
Zhernakova DV, Sinha T, Andreu-Sánchez S, Prins JR, Kurilshikov A, Balder JW, et al. Age-dependent sex differences in cardiometabolic risk factors. Nat Cardiovasc Res. 2022;1:844–854.
Spaziani M, Tarantino C, Tahani N, Gianfrilli D, Sbardella E, Lenzi A, et al. Hypothalamo-Pituitary axis and puberty. Mol Cell Endocrinol. 2021;520:111094.
Breehl L, Caban O. Physiology, Puberty. StatPearls. Treasure Island (FL) 2023.
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22:1999–2009.
Xu Q, Zhang J, Han H, Chen N, Lai F, Liu Y, et al. Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study. BMJ Open. 2022;12:e057820.
Valenzuela PL, Carrera-Bastos P, Castillo-Garcia A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20:475–94.
Drozdz D, Alvarez-Pitti J, Wojcik M, Borghi C, Gabbianelli R, Mazur A, et al. Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood. Nutrients. 2021;13:4176.
Marzuillo P, Grandone A, Perrone L, Miraglia Del Giudice E. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World J Gastroenterol. 2015;21:6444–50.